You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: February 29, 2024

Sk Life Company Profile


✉ Email this page to a colleague

« Back to Dashboard


Summary for Sk Life
International Patents:23
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Sk Life

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-006 Mar 10, 2020 RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-006 Mar 10, 2020 RX Yes No 7,598,279 ⤷  Try a Trial Y ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-006 Mar 10, 2020 RX Yes No 11,654,133 ⤷  Try a Trial ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-005 Mar 10, 2020 RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-003 Mar 10, 2020 RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-002 Mar 10, 2020 RX Yes No ⤷  Try a Trial ⤷  Try a Trial
Sk Life XCOPRI cenobamate TABLET;ORAL 212839-001 Mar 10, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Sk Life Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1879873 21C1027 France ⤷  Try a Trial PRODUCT NAME: CENOBAMATE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE: EU/1/21/1530 20210330
1879873 C202130027 Spain ⤷  Try a Trial PRODUCT NAME: CENOBAMATO; NATIONAL AUTHORISATION NUMBER: EU/1/21/1530; DATE OF AUTHORISATION: 20210326; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/21/1530; DATE OF FIRST AUTHORISATION IN EEA: 20210326
1879873 CA 2021 00015 Denmark ⤷  Try a Trial PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330
1879873 2190019-6 Sweden ⤷  Try a Trial PRODUCT NAME: CENOBAMATE OR A PHARMACEUTICAL ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/21/1530 20210330
1879873 2021C/524 Belgium ⤷  Try a Trial PRODUCT NAME: CENOBAMAAT; AUTHORISATION NUMBER AND DATE: EU/1/21/1530 20210330
1879873 CR 2021 00015 Denmark ⤷  Try a Trial PRODUCT NAME: CENOBAMAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/21/1530 20210330
1879873 122021000027 Germany ⤷  Try a Trial PRODUCT NAME: CENOBAMAT; REGISTRATION NO/DATE: EU/1/21/1530 20210326
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.